Skip to main content
OpenTrials

Clinical trial condition

Respiratory Hypersensitivity

Explore clinical trials studying Respiratory Hypersensitivity. Study availability and eligibility vary by location and protocol.

4,456 public trials 325 recruiting studies
Refine in advanced search Browse all conditions

Respiratory Hypersensitivity trial results

Completed

Fluticasone Furoate Nasal Spray Versus Oral Fexofenadine

NCT00502775

Conditions
Hypersensitivity, Hypersensitivity, Immediate, Immune System Diseases, +7 more
Locations
  • GSK Investigational Site Little Rock, Arkansas, United States
  • GSK Investigational Site Albany, Georgia, United States
  • GSK Investigational Site Columbus, Georgia, United States
  • GSK Investigational Site Lawrenceville, Georgia, United States
View all 42 locations
View Trial Details
Completed

A 12-Month Study Comparing Fluticasone Propionate/Salmeterol (ADVAIR) DISKUS Combination Product 250/50mcg BID To Fluticasone Propionate (FLOVENT) DISKUS 250 mcg BID In Symptomatic Subjects With Asthma

NCT00452699

Conditions
Asthma, Bronchial Diseases, Hypersensitivity, +6 more
Locations
  • GSK Investigational Site Scottsdale, Arizona, United States
  • GSK Investigational Site Little Rock, Arkansas, United States
  • GSK Investigational Site Fountain Valley, California, United States
  • GSK Investigational Site Los Angeles, California, United States
View all 74 locations
View Trial Details
Completed

Safety and Efficacy of GW685698X an Inhaled Corticosteroid Once Daily and Twice Daily for the Treatment of Asthma

NCT00766090

Conditions
Asthma, Bronchial Diseases, Hypersensitivity, +6 more
Locations
  • GSK Investigational Site Long Beach, California, United States
  • GSK Investigational Site Long Beach, California, United States
  • GSK Investigational Site Torrance, California, United States
  • GSK Investigational Site Cocoa, Florida, United States
View all 16 locations
View Trial Details
Completed

A Study To Determine The Effect Of SB-480848 On Asthma

NCT00368576

Conditions
Arterial Occlusive Diseases, Arteriosclerosis, Asthma, +11 more
Locations
  • GSK Investigational Site Cypress, California, United States
  • GSK Investigational Site Normal, Illinois, United States
  • GSK Investigational Site North Dartmouth, Massachusetts, United States
  • GSK Investigational Site Spartanburg, South Carolina, United States
View Trial Details

Related conditions